C. Kwon

发表

Effect of donor-recipient age gradient on graft outcomes in deceased donor liver transplantation.

J. Joh, J. M. Kim, M. Shin, 2013, Transplantation proceedings.

Mycophenolic acid trough level measurements and clinical outcomes in kidney transplantation recipients on a fixed dose (1.5 g/d) of mycophenolate mofetil in Korea.

J. Joh, S. Kim, G. Choi, 2010, Transplantation proceedings.

Use of Dexmedetomidine in Liver Transplant Recipients With Postoperative Agitated Delirium.

J. Joh, J. Ko, M. Gwak, 2016, Transplantation proceedings.

Case‐matched comparison of ABO‐incompatible and ABO‐compatible living donor liver transplantation

D. Sinn, J. Joh, E. Kang, 2016, The British journal of surgery.

Outcome of patients with recurrent hepatocellular carcinoma in liver transplantation.

J. Heo, J. Joh, S. Kim, 2006, Transplantation proceedings.

Reconstitution of human lymphocytes following ex vivo expansion of human umbilical cord blood CD34+ cells and transplantation in Rag2-/- gamma c-/- mice model.

K. Park, J. Joh, S. Kim, 2008, Transplantation proceedings.

Importance of donor-recipient age gradient to the prediction of graft outcome after living donor liver transplantation.

J. Joh, J. M. Kim, M. Shin, 2013, Transplantation proceedings.

Comparison of outcomes of living and deceased donor kidney grafts surviving longer than 5 years in Korea.

J. Joh, S. Kim, G. Choi, 2010, Transplantation proceedings.

Alemtuzumab induction in deceased donor kidney transplantation.

J. Joh, J. M. Kim, M. Shin, 2011, Transplantation proceedings.

Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.

J. Joh, S. Kim, Y. Choe, 2010, Transplantation proceedings.

Pharmacokinetics of mycophenolic acid in living donor liver transplantation.

J. Joh, G. Choi, J. M. Kim, 2010, Transplantation proceedings.

Can preemptive kidney transplantation guarantee longer graft survival in living-donor kidney transplantation? Single-center study.

G. Choi, G. Jung, J. M. Kim, 2010, Transplantation proceedings.

The effect of cytomegalovirus antigenemia titer on the efficacy of preemptive therapy for the prevention of cytomegalovirus disease after kidney transplantation.

J. Joh, G. Choi, G. Jung, 2010, Transplantation proceedings.

Outcomes of hepatitis B virus recurrence after liver transplantation.

J. Joh, S. Kim, D. Kim, 2006, Transplantation proceedings.

Effectiveness of intraportal prostaglandin E1 administration after liver transplantation.

J. Joh, M. Shin, C. Kwon, 2012, Transplantation proceedings.

Risk factors for portal vein complications after pediatric living donor liver transplantation with left-sided grafts.

J. Joh, G. Choi, G. Jung, 2010, Transplantation proceedings.

Prognosis after liver transplantation predicted by preoperative MELD score.

S. Kim, D. Kim, Soohyeon Lee, 2006, Transplantation proceedings.

The risk factors for cytomegalovirus syndrome and tissue-invasive cytomegalovirus disease in liver transplant recipients who have cytomegalovirus antigenemia.

J. Joh, S. Kim, G. Choi, 2010, Transplantation proceedings.

Monitoring and treatment for BK virus after kidney transplantation.

J. Joh, S. Kim, J. M. Kim, 2013, Transplantation proceedings.

Clinical significance of posttransplantation vesicoureteral reflux during short-term period after kidney transplantation.

J. Joh, S. Kim, G. Choi, 2008, Transplantation proceedings.

Kidney donation after cardiac death in Korea.

J. Joh, J. M. Kim, M. Shin, 2011, Transplantation proceedings.

Hormonal differences between female kidney transplant recipients and healthy women with the same gynecologic conditions.

J. Joh, S. Kim, W. Huh, 2012, Transplantation proceedings.

Living donor liver transplantation in Budd-Chiari syndrome: a single-center experience.

J. Joh, S. Kim, G. Choi, 2010, Transplantation proceedings.

Steroid withdrawal in adult liver transplantation: occurrence at a single center.

J. Joh, J. M. Kim, M. Shin, 2010, Transplantation proceedings.

Presence of vesicoureteral reflux in the graft kidney does not adversely affect long-term graft outcome in kidney transplant recipients.

J. Joh, H. Oh, J. M. Kim, 2013, Transplantation proceedings.

Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study.

J. Joh, S. Kim, W. Huh, 2012, Transplantation Proceedings.

Renal transplantation in patients with a small bladder.

J. Joh, S. Kim, G. Choi, 2008, Transplantation proceedings.

Can the kidney weight and recipient body weight ratio predict long-term graft outcome in living donor kidney transplantation?

J. Joh, S. Kim, W. Huh, 2013, Transplantation proceedings.

Implication of donor-recipient age gradient in the prognosis of graft outcome after deceased-donor kidney transplantation.

J. Joh, J. M. Kim, M. Shin, 2013, Transplantation proceedings.

The risk factors of delayed graft function and comparison of clinical outcomes after deceased donor kidney transplantation: single-center study.

G. Choi, G. Jung, J. M. Kim, 2010, Transplantation proceedings.

Liver transplantation in lymphoma patients with hepatitis B virus reactivation.

J. Joh, S. Kim, J. M. Kim, 2013, Transplantation proceedings.

Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?

J. Joh, S. Kim, G. Choi, 2010, Transplantation proceedings.

Laparoscopic right posterior sectionectomy versus laparoscopic right hemihepatectomy for hepatocellular carcinoma in posterior segments: Propensity Score Matching Analysis

J. Joh, J. M. Kim, J. Rhu, 2018, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

Comparison between resection and transplantation in combined hepatocellular and cholangiocarcinoma.

J. Joh, S. Kim, J. M. Kim, 2013, Transplantation proceedings.

Isolation and characterization of mouse mesenchymal stem cells.

J. Joh, G. Choi, J. Chun, 2008, Transplantation proceedings.

Comparison between thymoglobulin and ATGAM as an induction agent in adult kidney transplantation: a single-center experience.

J. Joh, S. Kim, H. Oh, 2012, Transplantation proceedings.

Early and delayed onset cytomegalovirus infection of liver transplant recipients in endemic areas.

J. Joh, S. Kim, G. Choi, 2010, Transplantation proceedings.

Clinical significance of proteinuria at posttransplant year 1 in kidney transplantation.

J. Joh, J. M. Kim, M. Shin, 2012, Transplantation proceedings.

Is it safe to use a kidney from an expanded criteria donor?

J. Joh, S. Kim, J. M. Kim, 2011, Transplantation proceedings.

Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.

J. Lee, K. Koh, S. Paik, 2012, Transplantation proceedings.

Comparison of the incidence of de novo malignancy in liver or kidney transplant recipients: analysis of 2673 consecutive cases in a single center.

J. Joh, J. M. Kim, M. Shin, 2013, Transplantation proceedings.

Kidneys from deceased donors with oliguria are feasible for kidney transplantation.

J. Joh, S. Kim, J. M. Kim, 2011, Transplantation proceedings.

Monitoring of cytomegalovirus-specific CD8+ T-cell response with major histocompatibility complex pentamers in kidney transplant recipients.

J. Joh, S. Kim, E. Shin, 2011, Transplantation proceedings.

Importance of donor-recipient age gradient to the prediction of graft outcome after living donor liver transplantation.

J. Joh, J. M. Kim, M. Shin, 2013, Transplantation proceedings.

Early postoperative renal dysfunction in the adult living donor liver transplantation.

J. Joh, G. Choi, J. Park, 2007, Transplantation proceedings.

Prognostic Factors Predicting Poor Outcome in Living-Donor Liver Transplantation for Fulminant Hepatic Failure.

J. Joh, S. Kim, J. M. Kim, 2017, Transplantation proceedings.